Join our newsletter


Spinal Muscular Atrophy: A Comprehensive Review of Newborn Screening, Treatment, and Ethical Cons...

By Danélia Botes

December 1, 2023

Understanding Spinal Muscular Atrophy (SMA) and the Importance of Early Detection Spinal Muscular Atrophy (SMA) is a rare genetic neuromuscular disorder characterised by significant morbidity and mortality. The condition results


Exploring the Potential of Generative Artificial Intelligence (GenAI) in Healthcare: Overcoming t...

By Danélia Botes

November 30, 2023

The Promise of GenAI in Healthcare Generative artificial intelligence (GenAI) tools like ChatGPT have excited the healthcare sector since their public release in late 2022. The sector sees GenAI’s potential


Igniting Drug Discovery in Africa: A Renewed Partnership

The Power of Partnership The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and H3D Foundation have recently announced a renewed three-year phase of their partnership. The aim is to


The Value-Based Pricing and Market Access of Valbenazine: A Cost Effective Evaluation in Japan

By Danélia Botes

November 29, 2023

The Centre for Outcomes Research and Economic Evaluation for Health (C2H) is an esteemed department of the National Institute of Public Health in Japan, established in 2018. The organisation conducts

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.



1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA



© 2023 Syenza™. All rights reserved.